OverviewChartNewsTraderScreen

HSBC Aktienanleihe BAYN 24.05.202.../  DE000HS3H7S8  /

EUWAX
10/05/2024  12:38:44 Chg.+1.75 Bid22:00:11 Ask22:00:11 Underlying Strike price Expiration date Option type
96.57EUR +1.85% -
Bid Size: -		 -
Ask Size: -		 BAYER AG NA O.N. 30.00 EUR 24/05/2024 Call
GlobeNewswire 02/05 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 18/04 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 16/04 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 11/04 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 09/04 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 25/03 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 14/03 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 06/03 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 05/03 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 04/03 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 04/03 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 15/02 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 13/02 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 13/02 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
TeleTrader 29/01 Bayer down over 5% after latest $2.25B Roundup ruling
TeleTrader 17/01 Bayer to cut jobs amid 'difficult situation'
GlobeNewswire 05/01 AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
GlobeNewswire 04/01 AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary end...
GlobeNewswire 14/12/2023 Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Su...
GlobeNewswire 06/12/2023 NFWF Announces $4.1 Million in Grants to Conserve the Monarch Butterfly and Other Insect Pollinators
TeleTrader 20/11/2023 Bayer's stock slumps over 16% on study halt, Roundup ruling
GlobeNewswire 09/11/2023 Bayer and Recursion Focus Research Collaboration on Oncology
GlobeNewswire 09/11/2023 Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NV...
TeleTrader 08/11/2023 Bayer reports sales of €10.3 billion in Q3
TeleTrader 08/08/2023 Bayer sales fall 14% to €11 billion in Q2